Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/4/25 16:43 | 3/4/25 | NTLA | Health | Diagn | In Vitro & In Vivo Diagnostic | Clark Eliana | MA | O | EVP,Chie | 2 | S.dm | -103 | 11.92 | 0 | -9 | 95 | D | |||||||||||||||
3/4/25 16:21 | 3/4/25 | NTLA | Health | Diagn | In Vitro & In Vivo Diagnostic | Basta James | MA | O | EVP,GC | 2 | S.d | -109 | 11.33 | 0 | -10 | 112 | D | |||||||||||||||
1/31/25 16:17 | 1/29/25 | NTLA | Health | Diagn | In Vitro & In Vivo Diagnostic | Bhanji Muna | MA | D | 1 | S | -3 | 9.97 | 0 | 0 | 19 | D | ||||||||||||||||
1/7/25 17:23 | 1/3/25 | NTLA | Health | Diagn | In Vitro & In Vivo Diagnostic | Dube Michael P | MA | O | VP,Chief | 1 | S | -17 | 12.18 | 0 | -1 | 46 | D | |||||||||||||||
1/7/25 17:20 | 1/3/25 | NTLA | Health | Diagn | In Vitro & In Vivo Diagnostic | Lebwohl David | MA | O | EVP,Chie | 2 | S.d | -116 | 9.13 | 0 | -13 | 97 | D | |||||||||||||||
1/7/25 17:20 | 1/3/25 | NTLA | Health | Diagn | In Vitro & In Vivo Diagnostic | Hicks Derek | MA | O | EVP,Chie | 1 | S | -79 | 12.18 | 0 | -7 | 60 | D | |||||||||||||||
1/7/25 17:19 | 1/3/25 | NTLA | Health | Diagn | In Vitro & In Vivo Diagnostic | Leonard John M | MA | DO | P,CEO | 2 | S.d | -327 | 9.42 | 0 | -35 | 1,026 | D | |||||||||||||||
1/7/25 17:16 | 1/3/25 | NTLA | Health | Diagn | In Vitro & In Vivo Diagnostic | Sepp-Lorenzino Laura | MA | O | EVP,Chie | 2 | S.d | -109 | 8.76 | 0 | -12 | 86 | D |
D | Derivative transaction in filing (usually option exercise) |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
A | Amended filing |
E | Error detected in filing |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |